Research Triangle Park, NC, United States of America

Daniel Larocque


Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Laval, CA (2015)
  • Research Triangle Park, NC (US) (2020 - 2021)

Company Filing History:


Years Active: 2015-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Larocque

Introduction

Daniel Larocque is a notable inventor based in Research Triangle Park, NC (US). He has made significant contributions to the field of immunogenic compositions, holding a total of three patents. His work focuses on advancing methods for producing immunogenic compositions that are crucial for medical applications.

Latest Patents

Among his latest patents, one notable invention relates to immunogenic compositions and methods for producing them. This invention specifically involves immunogenic compositions that comprise a protein antigen cross-linked to an oxoadenine adjuvant. This innovative approach has the potential to enhance the efficacy of vaccines and other immunological therapies.

Career Highlights

Daniel Larocque is currently employed at GlaxoSmithKline Biologicals SA, where he continues to push the boundaries of research in immunology. His work at this leading pharmaceutical company allows him to collaborate with other experts in the field and contribute to groundbreaking advancements in vaccine development.

Collaborations

Some of his notable coworkers include David Burkhart and Michael Cochran. Their collaborative efforts in research and development have further enriched the innovative environment at GlaxoSmithKline Biologicals SA.

Conclusion

Daniel Larocque's contributions to the field of immunogenic compositions exemplify the impact of dedicated inventors in advancing medical science. His innovative patents and collaborative work continue to pave the way for future breakthroughs in immunology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…